Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection

Abroad (travel likely)RecruitingPHASE4

Conditions

Newly Diagnosed · High Risk · MRD · Multiple Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (Chengcheng Fu, Ph D) · 13962191404

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma

Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2

Amiens, France · Angers, France

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma · RISS Stage I Plasma Cell Myeloma · RISS Stage II Plasma Cell Myeloma

Abroad (travel likely)RecruitingPHASE3

Anchorage, United States · Anchorage, United States

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma (MM)

Abroad (travel likely)RecruitingPHASE1

Springdale, United States · Jacksonville, United States

Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

High Risk Myelodysplastic Syndrome · Recurrent Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States